Preferred Label : isatuximab;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3299691/fr/sarclisa-isatuximab-myelome-multiple
2021
false
false
false
France
evaluation of the transparency committee
Myeloma
indicators and reagents
multiple myeloma
Sarclisa
indication of
indicators
traction
Myeloma
isatuximab
multiple myeloma
isatuximab

---
Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.